Gene · 4017
Papers2,536
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,536
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Multi-Faceted Approach to Explore the Role of Inflammatory CAFs, Providing Prognostic Value and Therapeutic Implications in Lung Adenocarcinoma. | Int J Genomics | 2025 | 41395115 | PubTator, text mining | PubMed |
| PARP9 drives the malignant progression of pancreatic cancer cells by regulating apoptosis, DNA damage, and multidrug efflux systems. | Front Cell Dev Biol | 2025 | 41357999 | PubTator, text mining | PubMed |
| The prediction value of LOXL-2 in the clinical pathology and prognosis of cancers: A meta-analysis and bioinformatics analysis. | Sci Rep | 2025 | 41354754 | PubTator, text mining | PubMed |
| ETV4 interacts with LOXL2 to induce epigenetic activation of NID1 during colorectal cancer progression. | Int J Biol Sci | 2025 | 41281746 | PubTator, text mining | PubMed |
| TFAM Loss Induces Oxidative Stress and Divergent Phenotypes in Glioblastoma Metabolic Subtypes. | Int J Mol Sci | 2025 | 41226485 | PubTator, text mining | PubMed |
| Modifications of the Secretome of Mesenchymal Stromal Cells under Conditions of Stress-Induced Aging. | Bull Exp Biol Med | 2025 | 41196481 | PubTator, text mining | PubMed |
| Lung endothelial PEAR1 induces tumor cell dormancy. | Mol Cancer | 2025 | 41185039 | PubTator, text mining | PubMed |
| Increased LOXL2 facilitates tissue remodeling in eosinophilic chronic rhinosinusitis with nasal polyps. | World Allergy Organ J | 2025 | 41143091 | PubTator, text mining | PubMed |
| Pathways to precision medicine in cervical cancer: a comprehensive review of small molecule inhibitors, biomarkers and computational approaches. | 3 Biotech | 2025 | 41113926 | PubTator, text mining | PubMed |
| Lysyl oxidase-like 2 inhibition ameliorated podocyte fibrosis by inhibiting transforming growth factor-beta signaling under high-glucose conditions. | Kidney Res Clin Pract | 2025 | 41035353 | PubTator, text mining | PubMed |
| Genomic medicine in hepatology: mechanisms and liver treatment strategies. | Mol Med | 2025 | 41023586 | PubTator, text mining | PubMed |
| Lysyl Oxidase-like 2-Guided Benefits of Early Cardiac Rehabilitation in Acute Heart Failure: A Prospective Cohort Study in Taiwan. | Biomedicines | 2025 | 41007790 | PubTator, text mining | PubMed |
| Integrative single-cell and machine learning approach to characterize immunogenic cell death and tumor microenvironment in LUAD. | J Transl Med | 2025 | 40993741 | PubTator, text mining | PubMed |
| Inhibition of LOXL2 Suppresses Nasal Mucosal Inflammation and Remodeling in Allergic Rhinitis. | J Asthma Allergy | 2025 | 40979914 | PubTator, text mining | PubMed |
| Knockdown of LOXL2 suppresses cuproptosis induced by H2O2 to inhibited the procession of ulcerative colitis. | Int Immunopharmacol | 2025 | 40925206 | PubTator, text mining | PubMed |
| Study of independent diagnostic efficacy and co-diagnostic strategies of molecular markers for diabetic cardiomyopathy. | Front Endocrinol (Lausanne) | 2025 | 40873950 | PubTator, text mining | PubMed |
| Lysyl oxidase as a potential biomarker of lung recurrence after hepatectomy in hepatocellular carcinoma. | Sci Rep | 2025 | 40858710 | PubTator, text mining | PubMed |
| B3GALT6 mutations lead to compromised connective tissue biomechanics in Ehlers-Danlos syndrome. | JCI Insight | 2025 | 40857410 | PubTator, text mining | PubMed |
| Role of the tumor microenvironment in promoting treatment resistance in urothelial carcinoma (Review). | Mol Med Rep | 2025 | 40849811 | PubTator, text mining | PubMed |
| Effects of Oxygen Manipulation on Myofibroblast Phenotypic Transformation in Patients With Radiation-Induced Fibrosis. | Wound Repair Regen | 2025 | 40824267 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4017/papers?page=5